oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
Clinical trial NCT05938296 · SUSPENDED
Trial details
- NCT number
- NCT05938296
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2026-12-19
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.